The Australian | Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada

Orthocell’s entry to to the Canadian market with the first sales of Striate+ has been reported in The Australian in the article “Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada”. The article outlines the swift transition from approval to revenue generation in this new market, and points to Striate+’s strong market acceptance and potential. Here’s an excerpt: “Strong sales traction in the existing markets has been driven by BioHorizons’ comprehensive marketing and medical education program, which has effectively informed clinicians about the benefits of Striate+. This success is further supported by Striate+’s outstanding 98.6% success rate in the post-market clinical study. Consequently, the product’s high-quality performance is motivating BioHorizons to pursue expansion into other large, attractive markets where they have established accounts and distribution networks.” Click here to read the article.